Thingstad et al. (Reports, 12 August 2005, p. 1068) reported that in situ mesoscale phosphorus enrichment of the eastern Mediterranean Sea altered selected biological parameters and concluded that the added phosphorus was rapidly transferred from bacteria to mesozooplankton. However, because of a lack of replication and a misinterpretation of their statistical analyses, that conclusion is not supported by the data.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1126/science.1126131 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Response Comment on "A New Immunogenic Structure of Polyepitopic Fusion against : In Silico Study".
Iran J Parasitol
January 2024
Department of Microbiology, Immunology, and Infectious Diseases, Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Role of diaphragmatic ultrasound in patients with acute exacerbation of chronic obstructive pulmonary disease.
World J Clin Cases
December 2024
Department of Medicine and Pharmacology, Texas A and M University, College Station, TX 77843, United States.
Assessing diaphragm function status is vital for diagnosing and treating acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Diaphrag-matic ultrasound has become increasingly important due to its non-invasive nature, absence of radiation exposure, widespread availability, prompt results, high accuracy, and repeatability at the bedside. The diaphragm is a crucial respiratory muscle.
View Article and Find Full Text PDFComment on 'Artificial Neural Network Inference Analysis Identified Novel Genes and Gene Interactions Associated With Skeletal Muscle Aging' by Tarum et al.
J Cachexia Sarcopenia Muscle
February 2025
School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.
On modes of disease transmission and the hidden shape of pandemics: A review of by Joshua Weitz.
Virus Evol
December 2024
Department of Ecology and Evolutionary Biology, Yale University, 165 Prospect Street, New Haven, CT 06511, USA.
The importance of asymptomatic transmission was a key discovery in our efforts to study and intervene in the COVID-19 pandemic. In (Johns Hopkins University Press, 2024), Joshua Weitz uses this aspect of SARS-CoV-2 natural history to discuss many counterintuitive characteristics of the pandemic. In this essay, I engage the arguments in the book, and discuss why asymptomatic transmission is such a critical dimension of the study of infectious diseases.
View Article and Find Full Text PDFMarstacimab: First Approval.
Drugs
December 2024
Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand.
Marstacimab (marstacimab-hncq; HYMPAVZI™) is a subcutaneously administered human monoclonal immunoglobulin G1 antibody against tissue factor pathway inhibitor (TFPI) that is being developed by Pfizer for the treatment of hemophilia A and B. Marstacimab received its first approval on 11 October 2024 in the USA. It was approved for use as routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A without factor VIII inhibitors or hemophilia B without factor IX inhibitors.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!